Existing investors contribute an additional $30 million to Inscripta to accelerate tools that will revolutionize genomic research Inscripta™, a leading gene-editing technology company, today announced that MAD7, its proprietary CRISPR enzyme, has achieved wide adoption by academic, commercial, and government … Continued
Inscripta’s MAD7 Named a Top Innovation of 2018 by The Scientist Gene editing has immense potential to advance and accelerate research of all kinds. Despite this, its potential to transform the world as we know it is limited by a … Continued
Crocus Technology Inc. Unveils Industry-Leading TMR-based Angular Sensor Crocus Technology Inc., a leading supplier of disruptive Tunnel Magneto-Resistance (TMR) sensors, today announces the CT300 device, a new break-through TMR-based angular (2D) magnetic sensor with an extremely low angular error and … Continued
SQZ Biotech expands cell therapy partnership with Roche to develop antigen presenting cells for immune-oncology SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the expansion of its collaboration with Roche (SIX: RO, … Continued
SQZ Biotech completes oversubscribed $72M Series C SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, announced the completion of an oversubscribed $72 million Series C financing. New investors include Everblue, Illumina Ventures, Invus, Orient … Continued
Lilly Completes Acquisition of ARMO BioSciences Eli Lilly and Company(NYSE: LLY) today announced the successful completion of its acquisition of ARMO BioSciences, Inc. (NASDAQ: ARMO). Lilly’s tender offer for all outstanding shares of common stock of ARMO, at a price of $50.00 per share … Continued
Founders Fund Leads $36 Million Financing Round in Emulate Emulate, Inc. today announced that it has secured a $36 million Series C financing round led by Founders Fund. The funding also includes additional new investors including ALS Investment Fund, SciFi VC, … Continued
Lilly Announces Agreement To Acquire ARMO BioSciences for $1.6B in an all-cash transaction Eli Lilly and Company (NYSE: LLY) and ARMO BioSciences, Inc. (NASDAQ: ARMO) today announced a definitive agreement for Lilly to acquire ARMO for $50 per share, or approximately $1.6 billion, in an all-cash … Continued
Organ-Chips Accurately Model and Predict Thrombotic Side Effect Caused by Anti-CD154 Monoclonal Antibody hu5c8; Emulate Publishes Results of Collaborative Research with Janssen Emulate, Inc. announced today a published study that demonstrates that its Blood Vessel-Chip accurately modeled and predicted thrombosis, … Continued
Crocus Technology Raises $35M in Financing Crocus Technology, a leading supplier of disruptive Tunnel Magneto-Resistance (TMR) sensors, today announces it has secured $35M in funding through a combination of debt and equity from internal investors and external sources. The funding … Continued